Wiley, 2002, Chem Phys Lipids, 121, 57, 10.1016/S0009-3084(02)00146-9
Mishima, 2001, Jpn J Pharmacol, 87, 297, 10.1254/jjp.87.297
Leker, 2003, Stroke, 34, 2000, 10.1161/01.STR.0000079817.68944.1E
Braida, 2003, Neurosci Lett, 346, 61, 10.1016/S0304-3940(03)00569-X
Mechoulam, 2002, J Clin Pharmacol, 42, 11S, 10.1002/j.1552-4604.2002.tb05998.x
Iuvone, 2004, J Neurochem, 89, 134, 10.1111/j.1471-4159.2003.02327.x
Hampson, 2002, Ann NY Acad Sci, 899, 274, 10.1111/j.1749-6632.2000.tb06193.x
Watanabe, 1996, Biol Pharm Bull, 19, 1109, 10.1248/bpb.19.1109
Bisogno, 2001, Br J Pharmacol, 134, 845, 10.1038/sj.bjp.0704327
Mishima, 2004, Behav Brain Res, 151, 209, 10.1016/j.bbr.2003.08.018
Nava, 2000, Pharmacol Biochem Behav, 66, 183, 10.1016/S0091-3057(00)00231-8
Egashira, 2004, Neurosci Lett, 363, 58, 10.1016/j.neulet.2004.03.046
Molina-Holgado, 2002, J Neurosci, 22, 9742, 10.1523/JNEUROSCI.22-22-09742.2002
Krieger, 2004, Stroke, 35, 1482, 10.1161/01.STR.0000126118.44249.5c
Zhao, 2004, Stroke, 35, 572, 10.1161/01.STR.0000110787.42083.58
Gerriets, 2003, Stroke, 34, 2234, 10.1161/01.STR.0000087171.34637.A9